Groundbreaking medical milestone achieved by Roberto D. Cervera, M.D. and Niranjan Seshadri, M.D. at Hays Medical Center’s Michael E. DeBakey Heart Institute of Kansas
HaysMed
Hays Medical Center proudly announces the successful completion of Kansas' first Percutaneous Transluminal Angioplasty with Bypass (PTAB) case, known as "The Detour" procedure. This remarkable achievement marks a significant milestone in the state's medical history, showcasing the advanced capabilities and expertise available at HaysMed.
The innovative "Detour" procedure was performed by a distinguished team of specialists, led by HaysMed cardiothoracic surgeon Dr. Roberto D. Cervera, a renowned expert in vascular cases, and Dr. Niranjan Seshadri, a highly esteemed cardiologist at HaysMed. Their collaboration and exceptional skills were pivotal in executing this complex and life-changing procedure, providing a new lease on life for patients with severe vascular conditions.
"We are incredibly proud of our team at HaysMed for successfully completing Kansas' first "Detour" procedure. The introduction of this advanced procedure and technology not only enhances the level of care we can offer but also underscores our commitment to improving health outcomes for our community and the entire region. This milestone represents a significant step forward in HaysMed’s mission to transform healthcare and deliver life-changing treatments to Kansans and beyond," said Eddie Herrman, HaysMed president and CEO.
About "The Detour" Procedure
"The Detour" procedure is a cutting-edge intervention designed to treat peripheral artery disease (PAD), a condition characterized by the narrowing or blockage of arteries in the limbs. This condition often leads to debilitating pain and, in severe cases, can result in limb loss. The PTAB procedure involves creating a new pathway for blood flow around the blocked arteries, effectively bypassing the obstruction and restoring adequate circulation to the affected areas.
Traditionally, treatment for PAD has included lifestyle changes, medication, and surgical interventions. However, "The Detour" offers a minimally invasive alternative, reducing the risk of complications and significantly shortening recovery times for patients. This revolutionary technique leverages advanced imaging technology and precision tools to create a new route for blood flow, enhancing patient outcomes and quality of life.
Expert Leadership and Collaboration
Dr. Cervera's extensive experience in vascular cases and Dr. Seshadri's expertise in cardiology played a crucial role in the successful completion of this procedure. Their combined knowledge and dedication to patient care ensured the highest level of precision and safety throughout the operation.
"We are thrilled to have successfully performed Kansas' first PTAB case with "The Detour" procedure," said Cervera. "This achievement underscores the commitment of HaysMed to providing cutting-edge treatments and improving the lives of our patients."
Seshadri added, "Collaboration and innovation are at the heart of what we do at HaysMed. The success of this procedure is a testament to our HaysMed DeBakey Heart Institute team's expertise and the importance of advancing medical care in our community."
The success of this groundbreaking procedure was also made possible by the expert support staff in the catheterization laboratory (cath lab) at HaysMed, whose expertise ensured a seamless and efficient operation.
A New Era in Vascular Treatment
The successful completion of "The Detour" procedure at HaysMed represents a significant advancement in the treatment of peripheral artery disease. It not only highlights the hospital's commitment to adopting the latest medical technologies but also positions HaysMed as a leader in vascular care in Kansas and beyond.
HaysMed is dedicated to offering the highest quality care to its patients, and this achievement is a testament to the hospital's ongoing efforts to push the boundaries of medical innovation. With a focus on patient-centered care and cutting-edge treatments, HaysMed continues to set new standards in the healthcare industry.